Renal and metabolic toxicities following initiation of HIV-1 treatment regimen in a diverse, multinational setting: A focused safety analysis of ACTG PEARLS (A5175)

by Touzard Romo,F., Smeaton,L.M., Campbell,T.B., Rivière,C., Mngqibisa,R., Nyirenda,M.J., Supparatpinyo,K., Kumarasamy,N., Hakim,J.G., Flanigan,T.P.
Published 2015